Erythromycin Market - Size, Share, Outlook, and Forecast till 2026

Erythromycin is an antibiotic used in the treatment or prevention of a wide range of bacterial infections. This antibiotic does not work in the event of viral infections such as common cold and flu. Erythromycin is thus used to treat respiratory tract infections, including bronchitis, pneumonia, Legionnaires' disease, and pertussis, diphtheria, as well as sexually transmitted diseases such as syphilis. It is also used to treat ear, intestine, gynecological, urinary tract, and skin infections. The erythromycin market is a rapidly growing market, as the drug is widely used across the globe and has been certified safe by the FDA.

Increasing prevalence of respiratory tract diseases due to growing volumes of toxic gases being let out in the environment is boosting demand for erythromycin, which in turn is fueling growth of the erythromycin market.

The downside of using this drug is that, it being an over-the-counter drug, it is often used for a variety of other purposes, even in mild cases or for non-bacterial infections. Using any antibiotic when it is not required causes the drug to not function for future infections. People thus, need to switch to other drugs instead of erythromycin. This in turn, poses a major restraint for growth of the erythromycin market.

Increasing number of companies are investing in the development of erythromycin owing to the lucrative opportunities, which in turn is augmenting growth of the erythromycin market.

In November 2017, Teligent, Inc.—a New Jersey-based specialty generic pharmaceutical company—received approval for its abbreviated new drug application (ANDA) from the U.S. FDA of Erythromycin Topical Solution USP, 2%.  This approval accounted for Teligent’s eighth approval during the same year and eighteenth approval from its internally-developed pipeline of topical generic pharmaceutical medicines.

In March 2018, Amneal Pharmaceuticals received FDA approval for Erythromycin Tablets USP for strengths of 250 mg and 500 mg.  The Amneal product is a therapeutic equivalent for the reference listed drug (RLD) Erythromycin Tablets from Arbor Pharmaceuticals and is the only other immediate release oral tablet available. The company sells its erythromycin tablets in 100-count bottles and has made them available to wholesalers, distributors, and direct to the trade.

Amneal aims at increasing access to affordable medications, and erythromycin tablets being products with limited availability, the company plans to benefit from the growing demand by providing patients and pharmacists with cost-effective options. According to January 2018 IQVIA market data, annual U.S. sales of erythromycin tablets accounted for US$ 84 million.

Global and Chinese Erythromycin Industry, 2018 Market Research Report

Published Date : Apr 2018

The 'Global and Chinese Erythromycin Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Erythromycin industry with a focus on the Chinese market. The report provides key statistics on the market status of the Erythromycin manufacturers...

Global Erythromycin Thiocyanate Market Outlook 2017-2022

Published Date : Nov 2017

Erythromycin thiocyanate is the nucleus of macrolide antibiotics and can be converted to various useful semisynthetic derivatives of erythromycin. This important intermediate is also used as important veterinary antibiotic. The report covers forecast and analysis for the erythromycin th...

2017 Europe Erythromycin Thiocyanate Industry Report

Published Date : Nov 2017

This report is an essential reference for who looks for detailed information on Europe Erythromycin Thiocyanate market. The report covers data on Europe markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Europe major vendor...

2017 India Erythromycin Thiocyanate Industry Report

Published Date : Nov 2017

This report is an essential reference for who looks for detailed information on India Erythromycin Thiocyanate market. The report covers data on India markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as India major vendors' ...

2017 Japan Erythromycin Thiocyanate Industry Report

Published Date : Nov 2017

This report is an essential reference for who looks for detailed information on Japan Erythromycin Thiocyanate market. The report covers data on Japan markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Japan major vendors' ...

2017 US Erythromycin Thiocyanate Industry Report

Published Date : Nov 2017

This report is an essential reference for who looks for detailed information on US Erythromycin Thiocyanate market. The report covers data on US and its regional markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as US major v...

2017 China Erythromycin Thiocyanate Industry Report

Published Date : Nov 2017

This report is an essential reference for who looks for detailed information on China Erythromycin Thiocyanate market. The report covers data on China and its regional markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Chin...

2017 Europe Erythromycin Lactobionate Industry Report

Published Date : Nov 2017

This report is an essential reference for who looks for detailed information on Europe Erythromycin Lactobionate market. The report covers data on Europe markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Europe major vendo...

2017 India Erythromycin Lactobionate Industry Report

Published Date : Nov 2017

This report is an essential reference for who looks for detailed information on India Erythromycin Lactobionate market. The report covers data on India markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as India major vendors'...

2017 Japan Erythromycin Lactobionate Industry Report

Published Date : Nov 2017

This report is an essential reference for who looks for detailed information on Japan Erythromycin Lactobionate market. The report covers data on Japan markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Japan major vendors'...

 

Select License :

  • Single User : $4500
  • Multiple User : $7000
  • Corporate User : $10000

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.